Ipilimumab is one of the advanced Immunotherapy medications available for the benefit of Cancer patients across the world. Prominently recognized for its efficacy as a therapeutic agent in the management of Melanoma and Renal Cell Carcinoma, it has been a drug of choice for many Oncologists. In combination treatment protocols, Ipilimumab and Nivolumab combination is deliberated by the experts. Its clinical data for NSCLC is impactful as yet. Yervoy is the brand name for Ipilimumab and can be access as Yervoy 200mg and Yervoy 50mg vials. As per the manufacturer’s specifications, Yervoy or Ipilimumab should be stored in 2 to 8 Degrees, at all times.
Yervoy 50mg and Yervoy 200mg approved by US FDA and EU EMA
Bristol-Myers Squibb is the innovator of Ipilimumab and Nivolumab, also the owner of the respective global brands. US FDA has approved Ipilimumab for the treatment of Melanoma in 2011 and European Union gave its approval in 2012. In Renal Cell Carcinoma, it is recommended as a therapeutic agent as part of the combination treatment. Ipilimumab cost has been a matter of concern and it is always debatable.
- The recent clinical research data presented in favor of Ipilimumab indicates its fast growing significance in the management of Melanoma. Irrespective of the aspects around Yervoy cost, the extended survival benefits for patients would make this a very relevant option.
- Non Small Cell Lung Cancer or NSCLC has been referred as one of the tumor types or solid tumor cancers with limited treatment options, from the view point of prolonged survival. Going by the clinical studies, both concluded and ongoing, it is natural and optimistic to believe in a very promising role for this drug in the future. Being an immunotherapy drug, many believe that Ipilimumab price comes with its set of benefits that include better quality of life.
Ipilimumab in India – Overview about the access and cost dynamics
Yervoy in India is not readily available for the patients because it is yet to be approved by the concerned drug authorities. Even though Ipilimumab and Nivolumab are widely prescribed by Medical Oncologists, the unavailability of Ipilimumab in India is a drawback. It is no surprise as the search trends for Ipilimumab cost in India suggest its relevance for domestic patients.
The unavailability of Yervoy in India need not hamper the treatment planning and schedule for the Indian patients. They can very well benefit from the provisions of Named Patient Services by exploring legal options of import. It is a common practice for the treating physicians to refer trusted sources for genuine import medicines to their patients. Therefore it is always a better idea to take assistance from the consultants and patients who are undergoing therapy with Yervoy or Ipilimumab in India. The cost is always subjective and several global factors are involved in determining it.
Authentic sourcing of Ipilimumab in India
Patients who are advised to be on Yervoy in India can procure a legal import permit from CDSCO. It’s the Indian regulatory for verifying the genuineness of the prescription and allowing patients to import limited quantities of unavailable drugs. They are strictly meant for personal use. The countries of Import can be USA, Germany, UK or Turkey. Engaging a seasoned entity that has already facilitated the import of Ipilimumab would be wise. That way, patients can optimize the time in just searching for sources online or contacting pharmaceutical dealers. It is always recommended to plan the import of the complete quantity for the required course of treatment. It would be essentially cost effective.
Contact Noel Biotech – +91 9677010046 / +91 992977766; firstname.lastname@example.org